Analysts' Actions: AMGN, DOW, GDOT, S, XOM

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

AmerisourceBergen ( ABC) upgraded at Baird from Neutral to Outperform, Robert Baird said. $46 price target. Comps are easing and earnings growth should accelerate.

Amgen ( AMGN) upgraded at Piper from Neutral to Overweight, Piper Jaffray said. $95 price target. Base business appears to have stabilized.

Acme Packet ( APKT) downgraded at Pacific Crest to Sector Perform, Pacific Crest said. Company is seeing lower orders from its largest customers.

BGC Partners ( BGCP) downgraded to hold at TheStreet Ratings.

Boston Scientific ( BSX) downgraded to sell at TheStreet Ratings.

Colgate-Palmolive ( CL) downgraded at Deutsche to Hold, Deutsche Bank said. Valuation call, based on a $105 price target.

Coinstar ( CSTR) downgraded at Pacific Crest from Outperform to Sector Perform, Pacific Crest said. Company is seeing slower growth at Redbox.

Dow Chemical ( DOW) downgraded at Morgan Stanley from Overweight to Equal-weight, Morgan Stanley said. Company faces macro headwinds in the near- and medium-term.

Emcor ( EME) downgraded at FBR from Outperform to Market Perform, FBR Capital Markets said. $26 price target. Organic backlog continues to decline.

Expedia ( EPXE) upgraded at Morgan Stanley to Equal-weight, Morgan Stanley said. Company has solid sales growth momentum.

Green Dot ( GDOT) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $20 price target. Estimates also cut, as the company slashed its guidance.

Green Dot downgraded at JMP from Outperform to Market Perform, JMP Securities said. Estimates also cut, as the company is facing increased competition.

Green Dot downgraded at KBW from Outperform to Market Perform, Keefe, Bruyette & Woods said. Estimates also cut, given the company's new guidance. $20 price target.

HealthSouth Corporation ( HLS) downgraded at Jefferies to Hold from Buy, Jefferies said. $23 price target. Rate risk rises. Hold rating.

Snyder's-Lance ( LNCE) rated new Hold at Deutsche Bank. Valuation call, based on a $24 price target.

MetroPCS ( PCS) upgraded at Deutsche to Buy. $12 price target. Stock still has another 40% upside potential, as expectations remain low.

QLogic ( QLGC) downgraded at Pacific Crest to Underperform, Pacific Crest said. Business is in a secular decline.

Raytheon ( RTN) downgraded at BofA/Merrill from Buy to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $56 price target.

Sprint Nextel ( S) upgraded at UBS to Buy from Neutral, UBS said. $6 price target. Better than expected NV, wireless environment.

Starbucks ( SBUX) downgraded at Baird from Outperform to Neutral, Robert Baird said. $50 price target. Sales have suddenly slowed down in recent months.

Valley National ( VLY) downgraded at JP Morgan to Underweight, JP Morgan said. Company is seeing a lower net interest margin and the dividend may be at risk.

Vistaprint ( VPRT) downgraded at Craig-Hallum from Buy to Hold, Craig-Hallum said. $35 price target. European business continues to slide.

ExxonMobil ( XOM) downgraded at UBS to Neutral from Buy, UBS said. $90 price target. Low quality 2Q EPS and premium multiple.

STOCK COMMENTS / EPS CHANGES

Amgen ( AMGN) estimates, target raised at Credit Suisse. Shares of AMGN now seen reaching $90, according to Credit Suisse. Estimates also increased, as the company should generate higher sales growth. Outperform rating.

Boston Scientific ( BSX) numbers reduced at Credit Suisse. Shares of BSX now seen reaching $6.50, according to Credit Suisse. Estimates also cut, as the company is realizing higher operating costs. Outperform rating.

BorgWarner ( BWA) added to Priority Stock List at Wells. BWA was placed on the Priority Stock list, according to Wells Fargo. Stock has lagged, though the company should be able to meet guidance in the coming quarters.

Borg Warner numbers cut at Citigroup. Shares of BWA now seen reaching $73, Citigroup said. Estimates also lowered as macro overshadows margin/booking positives. Neutral rating.

CA ( CA) numbers lowered at Oppenheimer. Shares of CA now seen reaching $28, Oppenheimer said. Estimates also lowered on cautious stance. Outperform rating.

Cameron ( CAM) estimates, target increased at Morgan Stanley. CAM estimates were raised through 2014, Morgan Stanley said. Company appears to be gaining market share. Overweight rating and nwe $72 price target.

Celgene ( CELG) numbers raised at Jefferies. Shares of CELG now seen reaching $80, Jefferies said. Estimates also raised on strong earnings. Buy rating.

Colgate-Palmolive ( CL) numbers raised at UBS. Shares of CL now seen reaching $104, UBS said. Estimates also increased as underlying fundamentals improve despite FX impact. Neutral rating.

Dow Chemical ( DOW) numbers lowered at UBS. Shares of DOW now seen reaching $36, UBS said. Estimates also lowered as back half of 2012 will be challenging.

Dow Chemical numbers lowered at Jefferies. Shares of DOW now seen reaching $29, Jefferies said. Estimates also lowered on extended soft patch. Hold rating.

Equinix ( EQIX) estimates, target increased at Deutsche. EQIX estimates were raised through 2013, Deutsche Bank said. Company is seeing strong core demand. Buy rating and new $230 price target.

Expedia ( EXPE) estimates, target boosted at Credit Suisse. Shares of EXPE now seen reaching $51, according to Credit Suisse. Estimates also upped, given higher realized conversion rates. Neutral rating.

Facebook ( FB) estimates, target cut at Wedbush. Shares of FB now seen reaching $35, according to Wedbush. Estimates also reduced, given higher spending on future business growth. Outperform rating.

Hill-Rom ( HRC) numbers reduced at Morgan Stanley. HRC estimates were cut through 2013, Morgan Stanley said. Company posted a disappointing outlook. Overweight rating and new $31 price target.

Hershey ( HSY) estimates, target increased at Morgan Stanley. HSY estimates were raised through 2014, Morgan Stanley said. Company is carrying a lot of business momentum into the second half of the year. Equal-weight rating and new $68 price target.

KBR ( KBR) estimates, target raised at Credit Suisse. Shares of KBR now seen reaching $48, according to Credit Suisse. Estimates also increased, given the company's new guidance. Outperform rating.

McKesson ( MCK) estimates, target raised at Credit Suisse. Shares of MCK now seen reaching $107, according to Credit Suisse. Estimates also increased, as the company should continue to exceed guidance. Outperform rating.

Mead Johnson ( MJN) numbers reduced at Credit Suisse. Shares of MJN now seen reaching $84, according to Credit Suisse. Estimates also cut, as trends remain soft in China. Outperform rating.

National Oilwell Varco ( NOV) numbers raised at Citigroup. Shares of NOV now seen reaching $96, Citigroup said. Estimates also increased on strong orders and guidance on rig tech market. Buy rating.

Occidental Petroleum ( OXY) numbers lowered at Credit Suisse. Shares of OXY now seen reaching $114, according to Credit Suisse. Estimates also cut, given reduced production growth expectations. Outperform rating.

Precision Castparts ( PCP) numbers boosted at Credit Suisse. Shares of PCP now seen reaching $191, according to Credit Suisse. Estimates also upped, as the company is realizing higher margins. Outperform rating.

MetroPCS ( PCS) numbers raised at UBS. Shares of PCS now seen reaching $9, UBS said. Estimates also increased on increasing margin outlook. Neutral rating.

Starbucks ( SBUX) estimates, target cut at Credit Suisse. Shares of SBUX now seen reaching $64, according to Credit Suisse. Estimates also reduced, as the company is seeing lower near-term sales and investing in new growth vehicles. Outperform rating.

Universal Health ( UHS) numbers reduced at Credit Suisse. Shares of UHS now seen reaching $51, according to Credit Suisse. Estimates also cut, as the company is cutting costs and the acute care business appears to be stabilizing. Outperform rating.

United Technologies ( UTX) numbers lowered at Jefferies. Shares of UTX now seen reaching $88, Jefferies said. Estimates also lowered on operational grind. Buy rating.

United Technologies numbers lowered at Oppenheimer. Shares of UTX now seen reaching $87, Oppenheimer said. Estimates also lowered on transitional year. Outperform rating.

Verisign ( VRSN) estimates, target raised at Credit Suisse. Shares of VRSN now seen reaching $50, according to Credit Suisse. Estimates also increased, as the company is realizing higher margins. Outperform rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.